Amgen and NSG BioLabs Extend Golden Ticket Award for Singapore Biotech, PairX Bio Wins Residency and Mentorship
ByAinvest
Wednesday, Jul 17, 2024 10:04 pm ET1min read
AMGN--
PairX Bio has won the Amgen Golden Ticket Award, receiving valuable support from Amgen and NSG BioLabs, as part of a three-year extension of the program. The award highlights Singapore's growing biotech sector, with a doubling of applicants this year. NSG BioLabs, partnering with CapitaLand, plans to expand its lab space to 70,000 square feet, cementing its position as the largest in Southeast Asia. The initiative aims to boost innovation and growth in the industry.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet